动物结核病疫苗市场：按类型、给药途径、目标动物和地区划分

2026年动物结核病疫苗市场规模估计为5,700万美元，预计2033年将达7,100万美元。预计2026年至2033年，该市场将以3.2%的复合年增长率成长。

结核病（TB）是由分枝桿菌属细菌引起的动物和人类性行为感染传染病，属于肉芽肿性疾病。结核病通常被认为是一种慢性且致残性疾病，但有时也会呈现急性且快速进展的病程。几乎所有脊椎动物都可能感染结核病。结核分枝桿菌（M. tuberculosis）多重抗药性（MDR）和广谱抗药性（XDR）菌株的广泛出现，令临床医生、公共卫生部门和监管机构对控制疾病感到担忧。牛结核病在世界非工业化国家仍然是重要的通用感染疾病。不同物种的症状和病变通常相似。结核分枝桿菌复合群（哺乳动物结核病）的主要菌种包括结核分枝桿菌（M. tuberculosis）、卡内蒂分枝桿菌（M. canettii）、牛分枝桿菌（M. bovis）、山羊分枝桿菌（M. caprae）、海豹分枝桿菌（M. pinnipedii）、小鼠分枝桿菌（M. microtirica）。鸟分枝桿菌复合群包括鸟分枝桿菌（M. avium avium，禽结核菌）、人鸟分枝桿菌（M. avium hominissuis，从人类、猪和其他哺乳动物分离得到）和胞内分枝桿菌（M. intracellular）。

市场动态

预计疫苗相关临床试验的增加将推动全球动物结核病疫苗市场在预测期内成长。

例如，根据多学科数位出版研究所2020年6月发布的报告，獾正在接受肌肉注射卡介苗（丹麦）疫苗以预防结核病。报告也指出，山羊正在接受肌肉注射热灭活牛分枝桿菌（HIMB）疫苗以预防结核病。

此外，政府部门加强对兽医结核病的宣传力度，预计将推动全球动物结核病疫苗市场在预测期内成长。

例如，2021年11月16日，英国政府宣布了一项结核病根除计画。该计划旨在英国进行结核病检测，以进一步降低结核病传播的风险。英国政府建议消费者在购买牛隻时充分了解相关信息，并披露待售牛隻的结核病情况。对于因结核病而被扑杀的牲畜，必须确保给予公平、适当且符合可用资金的补偿。

本报告的主要特点

• 本报告指出了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本文根据以下参数，介绍了全球动物结核病疫苗市场主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
• 《全球动物结核病疫苗市场》报告针对该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球动物结核病疫苗市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 机会
• 影响分析
• 主要进展
• 产业趋势
• 法规环境
• 近期产品核可上市
• PEST分析
• 波特五力分析

第四章：全球动物结核病疫苗市场：按类型划分（2026-2033 年）

• 活病毒疫苗
• 失活

第五章：全球兽用结核病疫苗市场：依给药途径划分（2026-2033 年）

• 皮下
• 肌肉内部
• 口服

第六章：全球动物结核病疫苗市场：依目标动物划分（2026-2033 年）

• 牛
• 狗
• 猫
• 其他的

第七章 全球动物结核病疫苗市场：依地区划分（2026-2033年）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • GCC
  • 以色列
  • 其他中东国家
• 非洲
• 南非
• 中非
• 北非

第八章 竞争情势

• 热图分析
• 市占率分析
  • Merck KGaA
  • Colorado Serum Company
  • CZ Vaccines（Zendal）
  • Zoetis Inc.

第九章

• 分析方法
• 关于 Coherent Market Insights

Veterinary Tuberculosis Vaccine Market is estimated to be valued at USD 57 Mn in 2026 and is expected to reach USD 71 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.2% from 2026 to 2033.

Tuberculosis (TB) is considered a reemerging, infectious granulomatous disease in animals and people caused by acid-fast bacilli of the genus Mycobacterium. Although commonly considered as a chronic, debilitating disease, TB occasionally assumes an acute, rapidly progressive course. The disease affects practically all species of vertebrates. The widespread occurrence of multidrug-resistant (MDR) strains and extensively drug-resistant (XDR) strains of M tuberculosis is of concern to clinicians and public health and regulatory officials involved in the control of the disease. Bovine TB is still a significant zoonosis in non-industrialized countries of the world. Signs and lesions are generally similar in the various species. The main types of M tuberculosis complex (mammalian tubercle bacilli) recognized are M tuberculosis, M canettii, M bovis, M caprae, M pinnipedii, M microti, M mungi, and M africanum. The M avium complex includes M avium avium (avian tubercle bacilli), M avium hominissuis (isolated from people, swine, and other mammals), and M intracellular.

Market Dynamics

Increasing undergoing trial for vaccination is expected to fuel growth of the global veterinary tuberculosis vaccine market over the forecast period.

For instance, according to a report published by Multidisciplinary Digital Publishing Institute in June 2020, BCG (Danish) vaccine type is administered by intramuscular to badgers for the prevention of tuberculosis. According to the same source, heat-inactivated Mycobacterium bovis vaccine (HIMB) is administered by intramuscular method to goats for the prevention of tuberculosis

Furthermore, increasing awareness programs for veterinary tuberculosis by government authorities is expected to drive growth of the global veterinary tuberculosis vaccine market over the forecast period.

For instance, on November 16, 2021, The Welsh Government, U.K. announced the Tuberculosis (TB) Eradication Programme. This program's goal was to offer a TB testing programme in Wales, U.K., in order to further lower the danger of the spread of TB. The Welsh Government, U.K. has advised to make informed purchase selections and to disclose TB information about any cattle they seek to sell. Payments for animals that were killed due to TB, to make sure the method is just and appropriate and takes into account the available funding.

Key features of the study

• This report provides an in-depth analysis of the global veterinary tuberculosis vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary tuberculosis vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck KGaA, Colorado Serum Company, CZ Vaccines (Zendal), and Zoetis Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary tuberculosis vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary tuberculosis vaccine market

Market Segmentation

• By Type
  • Live Attenuated
  • Inactivated
• By Route of Administration
  • Sub-cutaneous
  • Intramuscular
  • Oral
• By Animal Type
  • Cattle
  • Dogs
  • Cats
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players
  • Merck KGaA
  • Colorado Serum Company
  • CZ Vaccines (Zendal)
  • Zoetis Inc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
• Impact Analysis
• Key Developments
• Industry Trends
• Regulatory Scenario
• Recent Product Approval/Launches
• PEST Analysis
• Porter's Analysis

4. Global Veterinary Tuberculosis Vaccine Market, By Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Live Attenuated
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Inactivated
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Veterinary Tuberculosis Vaccine Market, By Route of Administration, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Sub-cutaneous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Intramuscular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Veterinary Tuberculosis Vaccine Market, By Animal Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Cattle
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Dogs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Cats
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Veterinary Tuberculosis Vaccine Market, By Region, 2026 - 2033 (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, For Regions, 2026 - 2033
  • Regional Trends
• North America
  • Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
  • Market Size and Forecast, By Region/Country, 2026 - 2033 (USD Mn)
• South Africa
• Central Africa
• North Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Colorado Serum Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CZ Vaccines (Zendal)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Analyst Views

9. Section

• Research Methodology
• About Us